Lobbying

Endo International's latest lobbying report covers Q2 2023, at $140K. Its first report covers Q4 2022.

Endo International

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Endo International lobbying by quarter
Endo International lobbying by quarter
QuarterAmountReports
Q4 2022$140K1
Q1 2023$140K1
Q2 2023$140K1
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

No issue reported.

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

No house or agency named.

Firms it paid

Firm
In-houseEndo International$420K3 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
23/07/20for Q2 2023In-house$140K
23/07/19for Q1 2023In-house$140K
23/07/19for Q4 2022In-house$140K
23/04/20for Q1 2023In-house$140K
23/01/20for Q4 2022In-house$140K